Logo

CellMax Life Receives NT$23M Grant From Taiwan Government for Cancer Early Detection Test

Jun 15, 2017 | staff reporter

NEW YORK (GenomeWeb) – Liquid biopsy firm CellMax Life said today that it has received an NT$23 million ($760,846) grant from the Taiwan Government Industrial Development Bureau Ministry of Economic Affairs. 

The company plans to use the funding to accelerate its efforts to automate its circulating tumor cell-based technology, and to advance plans for world-wide commercialization of its early cancer detection platform CMxTM.

CellMax Life President and CEO Atul Sharan said in a statement that the grant will allow the company to more rapidly expand the availability of the CMxTM platform and the blood-based screening test the company has developed for colorectal cancer, which it launched in Taiwan last year.

Filed under

Business News
Cancer
Liquid Biopsy
Colorectal Cancer
CTCs
Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.